Literature DB >> 9036862

Metanestin, a glycoprotein with metastasis-associated expression in transitional cell carcinoma of the urinary bladder.

M Takemoto1, T Shirahama, T Miyauchi, T Matsusako, N Kaneda, H Muramatsu, M Ozawa, Y Ohi, T Muramatsu.   

Abstract

A 60-kDa glycoprotein named metanestin was identified by molecular cloning. The glycoprotein had a twice-repeated motif of Pro-Gly-Pro-Gly and carried metastasis-associated carbohydrate epitopes. The antibody to the protein portion of metanestin strongly reacted with lymph-node metastasis of transitional-cell carcinoma of the urinary bladder, but the reactivity to the primary tumor was generally weaker and the normal urothelium was scarcely reactive. Thus both metanestin and the carbohydrate on it showed metastasis-associated expression. In addition, we identified a 100-kDa glycoprotein with a 4-times-repeated motif of Pro-Ala-Pro-Ala. The antibody to the 100-kDa glycoprotein showed reactivity similar to that to metanestin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9036862     DOI: 10.1002/(sici)1097-0215(19970220)74:1<7::aid-ijc2>3.0.co;2-6

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.

Authors:  Shuichi Tatarano; Takeshi Chiyomaru; Kazumori Kawakami; Hideki Enokida; Hirofumi Yoshino; Hideo Hidaka; Nijiro Nohata; Takeshi Yamasaki; Takenari Gotanda; Tokushi Tachiwada; Naohiko Seki; Masayuki Nakagawa
Journal:  Int J Oncol       Date:  2011-12-13       Impact factor: 5.650

2.  LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.

Authors:  R Matsuda; H Enokida; T Chiyomaru; N Kikkawa; T Sugimoto; K Kawakami; S Tatarano; H Yoshino; K Toki; Y Uchida; K Kawahara; K Nishiyama; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

3.  Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.

Authors:  R Matsushita; N Seki; T Chiyomaru; S Inoguchi; T Ishihara; Y Goto; R Nishikawa; H Mataki; S Tatarano; T Itesako; M Nakagawa; H Enokida
Journal:  Br J Cancer       Date:  2015-06-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.